Introduction
============

Automatic blood pressure (BP) measuring devices are more and more often used for BP self-checks and in 24-hour BP monitoring. According to the experts of European Society of Hypertension, 24-hour BP monitoring has been used for research purposes and at present it is mandatorily used in clinical and pharmacological studies and in evaluation of the efficiency of new antihypertensive medical products. Nowadays, 24-hour BP monitoring becomes an obligatory procedure in arterial hypertension detection. Considering the abovementioned, it is essential to objectively evaluate the accuracy of measurements performed by 24-hour BP monitoring devices offered in the market.

In 1990, the British Hypertension Society published a protocol, the purpose of which was to standardize the validation of noninvasive BP measuring instruments.[@b1-mder-4-193] This protocol was revised in 1993 and has gained international status.[@b2-mder-4-193] In 2004, the British Hypertension Society together with European Society of Hypertension (ESH) published an international standard for the validation of noninvasive sphygmomanometers.[@b3-mder-4-193] The principles recommended in the documents provided the basis for work aimed at the validation of the 24-hour BP monitoring device, BPLab^®^ (Petr Telegin Ltd, Nizhny Novgorod, Russia). The results of this validation are given below.

Methods
=======

Subject selection
-----------------

Subject selection was based on the requirements of the Standard EN 1060-4:2004.[@b3-mder-4-193] A group of 85 patients of both sexes and different ages, who voluntarily agreed to take part in the tests and were given detailed instructions on the measurement technique, were recruited to participate in this study. All participants provided verbal informed consent of study participation.

The statistical distribution of the patients' clinical profile parameters is given in [Table 1](#t1-mder-4-193){ref-type="table"}, and their distribution according to the BP level in [Table 2](#t2-mder-4-193){ref-type="table"}.

Exclusion criteria include: heart failure; significant rhythm disturbances or presence of an artificial pacemaker; pregnancy; and body mass index (BMI) \>30 kg/m^2^.

Test measurement conditions
---------------------------

In accordance with the requirements of the BHS-93 protocol, the results of the BP measurement obtained by a qualified operator using the BPLab device were compared with the BP values measured using the Korotkov auscultatory method simultaneously by two expert medical specialists with over 10 years of experience, who had completed a noninvasive BP measurement standardization training course. The measurements were taken in the morning in comfortable settings (ambient temperature 22°C--25°C, no stimulatory sights or sounds, etc), after the patients had been relaxing in a seated position for 10 minutes. The patients were prohibited to take alcohol \<24 hours beforehand or to smoke or take stimulants (tea, coffee, etc) \<8 hours before the measurement; they were only allowed to have a light breakfast not less than half an hour before the test. Additionally, taking medication that has a strong effect on the cardiovascular system was not allowed on the day of the measurements.

Expert BP measurements were performed by two experts simultaneously with usage of a high-quality auscultoscope with one head and two headbands, and two individual calibrated sphygmomanometers. The collar dimension depended on the patient's shoulder girth.

Measurement schedule
--------------------

The BP of each patient was measured nine times -- alternating between the experts and the tested device -- according to the following schedule:

1.  Measurement A: expert

2.  Measurement B: instrument

3.  Measurement 1: expert

4.  Measurement 2: instrument

5.  Measurement 3: expert

6.  Measurement 4: instrument

7.  Measurement 5: expert

8.  Measurement 6: instrument

9.  Measurement 7: expert

The BP was measured on the nondominant arm. The interval between measurements was 30--60 seconds. The BP values obtained by the experts were recorded by each of them according to their own protocol. Three measurement error values were calculated for each patient (for systolic BP \[SBP\] and diastolic BP \[DBP\], separately) according to the following formulae:
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where BP~n~ is a BP measurement result corresponding to the measurement number n. Measurement A was used to refer a patient to this or that group according to their BP level; measurement B was treated as a calibration measurement.

Discrepancies in the systolic and diastolic BP measurements (N = 510; 255 for each expert) were subsequently analyzed according to the criteria specified in the BHS-93 protocol.

Results
=======

Detailed results of the data analysis are given in [Table 3](#t3-mder-4-193){ref-type="table"} in the form recommended by the BHS-93 protocol.[@b2-mder-4-193] The number of measurement error values which are within the ranges envisaged by the protocol is indicated in the form of a percentage ratio in relation to the total number of measurements.

[Figure 1](#f1-mder-4-193){ref-type="fig"} is a graphical illustration of discrepancies of each measurement depending on the relevant BP value (separately for SBP and DBP). As recommended in the BHS-93 protocol, the figures show only the results of comparison with the expert who obtained closer results (for SBP -- observer 2, for DBP -- observer 1).

Discussion
==========

Recently, the accuracy of conventional sphygmomanometers for the measurement of BP has been called into question, and much effort has been made to improve the quality of automatic device measurements.[@b5-mder-4-193] Ambulatory BP monitoring is being increasingly recommended for routine clinical practice because it provides valued prognostic data.[@b6-mder-4-193],[@b7-mder-4-193] The accuracy of BP measuring devices is of great importance and should be validated before devices are put into operation. The aim of this study was to validate the accuracy of the BPLab^®^ 24-hour ambulatory BP monitoring device (Petr Telegin Ltd, Nizhny Novgorod, Russia).

The results of this study suggest that the BPLab^®^ 24-hour ambulatory BP monitoring device passes the test carried out in a mixed group of patients in accordance with the requirements of the European Standard BS EN 1060-4:2004 and the BHS-93 protocol, and may be categorized in the 'A' accuracy class according to the abovementioned protocol. The tested device may be recommended for extensive clinical use.
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###### 

Patients' clinical profile parameters

  Parameter               Mean   SD   Min      Max
  ----------------------- ------ ---- -------- -----
  Age                     37     15   18       87
  SBP, mmHg               134    25   64       198
  DBP, mmHg               85     16   44       122
  Arm circumference, cm   31     7    21       44
  Sex                     Male        Female   
                          49          36       

**Abbreviations:** SD, standard deviation; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure.

###### 

Distribution of patients according to BP level

  ----- ------------- ------ --------- ---------- ---------- -------
  SBP   Range, mmHg   \<90   90--129   130--160   161--180   \>180
        No            8      22        23         20         9
        \%            9.4    25.9      27.1       23.5       10.6
  DBP   Range, mmHg   \<60   60--79    80--100    101--110   \>110
        No            8      21        26         20         10
        \%            9.4    24.7      30.6       23.5       11.8
  ----- ------------- ------ --------- ---------- ---------- -------

**Abbreviations:** BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure.

###### 

Study results

                            Difference between standard and test device (%)   Grade   AAMI criteria                    
  ------------------------- ------------------------------------------------- ------- --------------- --- ------ ----- --------
  **Observer 1**                                                                                                       
  SBP                       65                                                89      98              A   1.2    6.5   Passed
  DBP                       61                                                87      97              A   −1.2   7.1   Passed
  **Observer 2**                                                                                                       
  SBP                       66                                                90      98              A   1.1    6.4   Passed
  DBP                       60                                                86      96              A   −1.4   7.4   Passed
  **Final grading**                                                                                                    
  SBP                       66                                                90      98              A   1.1    6.4   Passed
  DBP                       61                                                87      97              A   −1.2   7.1   Passed
  **Observer comparison**                                                                                              
  SBP                       84                                                99      100                 0.2    2.2   
  DBP                       81                                                95      100                 −0.9   3.8   

**Abbreviations:** SD, standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure; AAMI, Association for the Advancement of Medical Instrumentation.
